Aimee Shu
Fortune : 429 619 $ au 31/05/2026
Fortune : 429 619 $ au 31/05/2026
Aimee D.
Shu currently holds the position of Chief Medical Officer & Executive VP at Ascendis Pharma A since 2024, with employment at the firm starting in 2017.
Additionally, Dr. Shu has been an Associate Professor of Medicine at Stanford University School of Medicine since 2016, with employment beginning in 2012.
The education history includes an undergraduate degree from Princeton University and a doctorate from Harvard Medical School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ASCENDIS PHARMA A/S -.--% | 31/12/2025 | 1 917 ( -.--% ) | 429 619 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ASCENDIS PHARMA A/S | Directeur Technique/Scientifique/R&D | 01/07/2017 |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/11/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national